These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9822920

  • 1. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma.
    Leong AS, Sormunen RT, Tsui WM, Liew CT.
    Histopathology; 1998 Oct; 33(4):318-24. PubMed ID: 9822920
    [Abstract] [Full Text] [Related]

  • 2. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS, Isa MR, Sherina MS, Rampal L, Hairuszah I, Sabariah AR.
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [Abstract] [Full Text] [Related]

  • 3. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD, Rege JD, Joshi AS, Vaiphei K, Amarapurkar DN.
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [Abstract] [Full Text] [Related]

  • 4. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
    Hanif R, Mansoor S.
    J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
    [Abstract] [Full Text] [Related]

  • 5. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK, Prakash S, Geller SA, Alsabeh R.
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA, Ahmed NS.
    Diagn Pathol; 2012 Oct 30; 7():149. PubMed ID: 23111165
    [Abstract] [Full Text] [Related]

  • 9. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
    Pour AM, Masir N, Rose IM.
    Malays J Pathol; 2016 Dec 30; 38(3):229-233. PubMed ID: 28028292
    [Abstract] [Full Text] [Related]

  • 10. Hep Par 1 in gastric and bowel carcinomas: an immunohistochemical study.
    Villari D, Caruso R, Grosso M, Vitarelli E, Righi M, Barresi G.
    Pathology; 2002 Oct 30; 34(5):423-6. PubMed ID: 12408340
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Immunohistochemical spectrum in the detection and differentiation of intrahepatic neoplasms].
    Cong W, Tan L, Zhang S, Xian Z, Wu W, Pan J, Zhang X.
    Zhonghua Zhong Liu Za Zhi; 2002 Nov 30; 24(6):553-6. PubMed ID: 12667323
    [Abstract] [Full Text] [Related]

  • 16. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY, Bourne PA, diSant'Agnese PA, Huang J.
    Am J Clin Pathol; 2006 Apr 30; 125(4):519-25. PubMed ID: 16627262
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
    Chu PG, Ishizawa S, Wu E, Weiss LM.
    Am J Surg Pathol; 2002 Aug 30; 26(8):978-88. PubMed ID: 12170084
    [Abstract] [Full Text] [Related]

  • 18. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimachi K, Tsuneyoshi M.
    Mod Pathol; 1996 Sep 30; 9(9):901-9. PubMed ID: 8878022
    [Abstract] [Full Text] [Related]

  • 19. The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma.
    Johnson DE, Herndier BG, Medeiros LJ, Warnke RA, Rouse RV.
    Am J Surg Pathol; 1988 Mar 30; 12(3):187-97. PubMed ID: 2449824
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.